The intervening years have both sped and crawled by, too busy at times to take stock of all that has changed, too plodding to ...

The only other human case of bird flu in the U.S. occurred in 2022 and may not have caused any illness, with the CDC stating that the "detection may have been the result of contamination of the nasal ...

New Year’s is receding fast in the rearview mirror. And for many of us, our sincere resolutions about losing weight and ...

Since their first cry, your baby has come a long way. If you observe your 2-month-old’s milestones, you’ll notice that your ...

Novavax (NASDAQ:NVAX), and other vaccine developers extended recent gains on Tuesday as investors reacted to rising flu and ...

Vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, while confidence in other vaccines remains unchanged.

BARDA tapped a team of Fred Hutch Cancer Center biostatisticians to determine the biomarkers that will serve as predictors of ...

Investors are weighing Nvidia's big AI plans and puzzling over Trump's tariff policy in the wait for fresh jobs data.

Funding enables development of vaccine platform CMTX-301 from lead optimization through Phase 1 clinical evaluation. Grant follows 2020 CARB-X award that successfully advanced CMT ...

Investors are weighing Nvidia's big AI plans and puzzling over Trump's tariff policy in the wait for fresh jobs data.

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...